Imatinib Tablets

Imatinib Tablets

2050 INR/Piece

Product Details:

  • Enzyme Types Other
  • Feature Food Grade
  • Ingredients Other
  • Fermentation Smell Normal Smell
  • Storage Instructions Room temperature
  • Shelf Life 2 Years
  • Supply Ability : 10000 Piece Per Week
  • Click to view more
X

Price And Quantity

  • 2050 INR/Piece
  • 10.00 - 100.00 INR/Piece
  • 5000-10000 Piece

Product Specifications

  • 2 Years
  • Other
  • Normal Smell
  • Food Grade
  • Other
  • Room temperature

Trade Information

  • Cash in Advance (CID), Cash Advance (CA), Cash Against Delivery (CAD)
  • 10000 Piece Per Week
  • 7-15 Days
  • Yes
  • Sample costs shipping and taxes has to be paid by the buyer
  • corrugated box
  • Africa, Central America, Australia, Asia
  • All India

Product Description

Brand Name:    Imatinib
Generic Name: Imatinib Mesylate
Manufacturer:  Taj Pharmaceuticals Limited
Form:              Tablet
Strength:         400 mg

Imatinib is used for treating certain type of cancer such as chronic myeloid leukemia, myelodysplastic/myeloproliferative diseases, lymphoblastic leukemia and gastrointestinal stromal tumors. It is a chemotherapy drug that works by slowing or preventing the growth of cancer cells in the body.

Imatinib mesylate is a tablets taken by mouth, once or twice daily as per prescribed by the doctor. It should be taken with a glass of water after a meal.

Common Side Effects:

  • Nausea and vomiting
  • Skin rash
  • Headache
  • Diarrhea
  • Fatigue
  • Joint pain
  • Weakness
  • Poor appetite
  • Constipation

Approx. Price : Rs 300 / Pack

Product Details :

Dose

As Prescribed

Form

Tablet

Generic Name

Imatinib

Manufacturer

Cipla Ltd

Packaging Size

1 x 10

Product Type

Finished Product

Syrength

400 Mg

Usage

Hospital,Clinical


VEA IMPEX

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.

Other Products in 'Anti Cancer Medicines & Injections' category



"We mainly deliver our products to the foreign countries."
Back to top